Compass Therapeutics Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -100.0% | |
| – | +10.4% | +13.4% | -32.4% | +17.2% | -0.7% | – | – | |
| – | – | – | – | – | – | – | -273.2% | |
| – | -17.1% | -33.6% | +36.5% | +47.5% | +27.1% | +11.1% | +32.2% | |
| – | +3.4% | +11.2% | -15.3% | +6.7% | +5.0% | +23.6% | +11.5% | |
| – | -11.1% | -18.3% | +194.4% | -49.1% | +20.9% | +14.1% | +24.2% | |
| – | – | – | – | – | – | – | – | |
| – | +60.1% | -26.1% | -59.3% | +537.8% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | -11.7% | -64.8% | +1,056.3% | -756.8% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.